Velocity Clinical Research, Los Angeles — Los Angeles, California

Velocity Clinical Research, Los Angeles is a clinical research site located in Los Angeles, California, United States 90057.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Velocity Clinical Research, Los Angeles has participated in 5 clinical trials with 4 currently active.

Therapeutic areas: SARS-CoV-2 Infection, COVID-19, SARS-COV-2 Infection.

Sponsors: BioNTech SE, Eli Lilly and Company, Sparrow Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Velocity Clinical Research, Los Angeles?

Velocity Clinical Research, Los Angeles has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Velocity Clinical Research, Los Angeles conducted?

Velocity Clinical Research, Los Angeles has 5 clinical trials on record, with 4 currently active. Their work covers SARS-CoV-2 Infection, COVID-19, SARS-COV-2 Infection.

Is Velocity Clinical Research, Los Angeles accredited by Crixeo Health?

Yes — Velocity Clinical Research, Los Angeles holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Velocity Clinical Research, Los Angeles?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.